- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 15.9962 ↓ -0.86%
[as on 16 April, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of quant Healthcare Fund - Growth Option - Direct Plan and its peers as on 16 April, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 32.34% | -4.87% |
Discrete returns (monthly)
| Month | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 |
|---|
| Returns | 2.45% | -2.43% | -0.14% | 0.25% | 1.27% | -0.5% | -1.78% | -5.07% | 2.58% | -5.34% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | -4.5% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 78.95% |
6.21% (Arbitrage: 0.00%) |
0.00% |
0.00% |
-3.65% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sequent Scientific Limited | SEQUENT (INE807F01027) | Pharmaceuticals & Biotechnology | 8.26% |
| Zydus Wellness Ltd | ZYDUSWELL (INE768C01028) | Food Products | 7.97% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 7.89% |
| SMS Pharmaceuticals Limited | SMSPHARMA (INE812G01025) | Pharmaceuticals & Biotechnology | 6.53% |
| Pfizer Ltd | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 6.51% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 6.45% |
| ANTHEM BIOSCIENCES LIMITED | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 6.17% |
| Adani Enterprises Limited | ADANIENT (INE423A01024) | Metals & Minerals Trading | 6.14% |
| Alivus Life Sciences | ALIVUS (INE03Q201024) | Pharmaceuticals & Biotechnology | 5.80% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 3.58% |
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 3.40% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 3.14% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.91% |
| Godrej Properties Limited | GODREJPROP (INE484J01027) | Realty | 2.80% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.41% |
Debt
| Name | Rating | Weight % |
|---|
| 91 Days Treasury Bill 18-Dec-2025 | N.A. | 1.81% |
| 91 Days Treasury Bill 20-Nov-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 28-Nov-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 04-Dec-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 02-Jan-2026 | N.A. | 0.77% |
| 91 Days Treasury Bill 15-Jan-2026 | N.A. | 0.77% |
| 91 Days Treasury Bill 23-Jan-2026 | N.A. | 0.51% |
Portfolio data is as on date 31 October, 2025
NAV history
quant Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 16 April, 2026 | 15.9962 | -0.86% |
| 15 April, 2026 | 16.1343 | 1.77% |
| 13 April, 2026 | 15.8532 | -0.03% |
| 10 April, 2026 | 15.8582 | 1.35% |
| 9 April, 2026 | 15.6476 | 0.67% |
| 8 April, 2026 | 15.5438 | 1.96% |
| 7 April, 2026 | 15.2447 | -0.44% |
| 6 April, 2026 | 15.3123 | 2.2% |
| 2 April, 2026 | 14.982 | -0.76% |
| 1 April, 2026 | 15.0967 | 1.9% |
| 31 March, 2026 | 14.815 | 0% |
| 30 March, 2026 | 14.8149 | -1.92% |
| 27 March, 2026 | 15.1045 | -0.77% |
| 25 March, 2026 | 15.2223 | 1.96% |
| 24 March, 2026 | 14.9302 | 2.9% |
| 23 March, 2026 | 14.509 | -3.08% |
| 20 March, 2026 | 14.9707 | 1.16% |
| 19 March, 2026 | 14.7997 | -2.86% |
| 18 March, 2026 | 15.2347 | 0.81% |
| 17 March, 2026 | 15.113 | 0.58% |
| 16 March, 2026 | 15.0257 | -0.33% |
| 13 March, 2026 | 15.0754 | -1.59% |
| 12 March, 2026 | 15.3196 | -0.27% |
| 11 March, 2026 | 15.3618 | -0.42% |
| 10 March, 2026 | 15.4271 | 2.34% |
| 9 March, 2026 | 15.0746 | -1.15% |
| 6 March, 2026 | 15.2494 | -0.24% |
| 5 March, 2026 | 15.2868 | 0.93% |
| 4 March, 2026 | 15.1463 | -1.32% |
| 2 March, 2026 | 15.349 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of quant Healthcare Fund - Growth Option - Direct Plan is 15.9962 as on 16 April, 2026.
What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan are 2.7% as on 16 April, 2026.
What are 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan are 9.82% as on 16 April, 2026.